Ads
related to: Acute Myeloid Leukemia- About FLT3m+ AML
Information on FLT3 Mutation
Positive Acute Myeloid Leukemia.
- Indication Information
View Important Safety Information
for a R/R FLT3m+ AML Treatment.
- Treatment Side Effects
View Important Side Effects and
Safety Information on HCP Site.
- Dosing & Administration
Find Dosing & Admin Information
for a R/R FLT3m+ AML Treatment.
- Request a Representative
Request a Rep to Learn More about
a Treatment for R/R FLT3m+ AML.
- Patient Support Programs
Discover Programs to Help Patients
Access a R/R FLT3m+ AML Treatment.
- About FLT3m+ AML
Chimerix, Exclusive Worldwide Licensee Of Cantex's Investigational Product, DSTAT, Has Announced...
TheStreet.com· 6 hours agoWESTON, Fla., Feb. 26, 2021 /PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing proprietary pharmaceuticals for
Overcoming chemotherapy resistance in leukemia with a diarrhea drug from Merck
FierceBiotech· 1 day agoAlthough acute myeloid leukemia (AML) is treatable with chemotherapy, patients often become...
Ohio State study suggests Black patients more likely to die of acute myeloid leukemia
The Lantern· 23 hours agoBlack patients below the age of 60 with acute myeloid leukemia, a rare, sudden bone marrow cancer, have a 28 percent higher chance of ...
FDA Places Clinical Hold on Sickle Cell Gene Therapy
Medscape· 3 days agoThe FDA placed a clinical hold yesterday on two gene therapy trials for sickle cell disease (SCD) after one participant developed acute myeloid
Leukemia: Why do Black adults have worse health outcomes?
Medical News Today· 1 day agoNew research examines racial disparities in a particularly aggressive form of blood cancer: acute ...
Is There Any Hope for bluebird bio Stock? | The Motley Fool
The Motley Fool· 3 days agoThe share price of bluebird bio (NASDAQ:BLUE) is down a staggering 70% over the past year. The...
Syros To Participate In Upcoming Investor Conferences In March
TheStreet.com· 4 days agoSyros Pharmaceuticals SYRS, a leader in the development of medicines that control the expression of genes, today announced that members of its management team
bluebird bio: Positive Resolution Of Clinical Hold Could Drive Asymmetrical Upside
TipRanks via Yahoo Finance· 4 days agoThe challenge facing BLUE is how to resolve the issues it encountered with one of its first patients...
Pleasant Valley teen raises funds for pediatric cancer research | Times News Online
Times News· 3 days agoHalloween was Schyler Herman’s favorite holiday. Moore, a senior and class president from Pleasant...
Intellia (NTLA) Miss Earnings & Revenues Estimates in Q4
Zacks via Yahoo Finance· 19 hours agoIntellia Therapeutics, Inc. NTLA is a clinical-stage company with focus on developing gene editing...
Ads
related to: Acute Myeloid Leukemia